Adverse events164

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 164

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Pyrexia	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	5	6
other	Pyrexia	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	4	6
other	Oedema peripheral	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	2	6
other	Oedema peripheral	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	4	6
other	Chills	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Chills	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Malaise	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Malaise	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Fatigue	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Fatigue	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	0	6
other	Oedema	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Oedema	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	0	6
other	Pain	General disorders	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	1	6
other	Pain	General disorders	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	0	6
other	Aspartate aminotransferase increased	Investigations	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	4	6
other	Aspartate aminotransferase increased	Investigations	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	4	6
other	Blood alkaline phosphatase increased	Investigations	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	3	6
other	Blood alkaline phosphatase increased	Investigations	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	2	6
other	Alanine aminotransferase increased	Investigations	Phase I: GSK2118436 150 mg + GSK1120212 2 mg	2	6
other	Alanine aminotransferase increased	Investigations	Phase II: GSK2118436 150 mg + GSK1120212 2 mg	1	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01928940/events

API reference For AI assistants

Adverse events164

Sources 3

Read this list from software.